Enzyme revealed as promising target to treat asthma, cancer

An enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies, report scientists, citing results of a recent mouse study. By untangling the different effects of SKG1, researchers have advanced efforts to fine-tune immune responses in patients. “We’re not suppressing or exacerbating the immune system, we’re regulating it,” the lead author noted. “We’re regulating it to do exactly what we want it to do.”